Role of DN T cells in colonic microbiota-immune system maturation
DN T 细胞在结肠微生物群免疫系统成熟中的作用
基本信息
- 批准号:9258021
- 负责人:
- 金额:$ 5.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAlpha CellAreaAutoimmune ProcessBasic ScienceBiochemicalBiologicalCD8-Positive T-LymphocytesCD8B1 geneCell physiologyCellsCharacteristicsChemistryColonCommunicable DiseasesComplexDataDiseaseDoctor of PhilosophyEnvironmentFlow CytometryFractionationFusobacteriaFusobacterium mortiferumFutureGerm-FreeGnotobioticGoalsHomeostasisHumanHuman MicrobiomeImmuneImmune systemImmunityImmunobiologyImmunologyIntestinesKnowledgeLeadershipLymphoid TissueMicrobiologyModelingMusPhysiologicalPopulationPostdoctoral FellowPrevalenceProtein AnalysisResearchRoleSensitivity Training GroupsSignal TransductionSiteSystemT-LymphocyteTechniquesTechnologyTimeTissuesTrainingbiomarker identificationcommensal microbesgastrointestinal epitheliumgut microbiotaimprovedinsightknowledge basemembermicrobialmicrobial communitymicrobiomemicrobiotamicroorganism interactionmouse modelnew therapeutic targetperipheral bloodpost-doctoral trainingskillstooltool developmenttranscriptome sequencing
项目摘要
Project Summary
`Double negative' (DN) T cells are an understudied group of T lymphocytes with unclear function. Preliminary
data shows that these cells are specifically expanded in colonic lymphoid tissue when GF mice are
monocolonized with specific members of the healthy human microbiota, especially Fusobacterium mortiferum.
These cells are a physiologically large component of the intestinal T cell population, constituting ~30% of
conventional colonic T cells, equal in proportion to CD4+ and CD8+ T cells. Despite this, they remain relatively
poorly understood. The purpose of DN T cell expansion, as well as the general role of F. mortiferum in the
healthy microbiota, is currently unknown. I propose that F. mortiferum educates the DN T cell population in the
colonic lymphoid tissue towards a specific function that aids in maturation of the healthy microbiota-immune
homeostasis. The goal of this proposal is to explore the function of these cells in the intestinal system of
healthy wildtype host. Two approaches will be taken in this exploration: 1) characterization of DN T cells
expanded in F. mortiferum monocolonization, and 2) biochemical fractionation of F. mortiferum to identify
which specific microbial components are actively involved with DN T cell expansion. This will be tackled
through my PhD expertise in immunobiology and infectious diseases, and expanded with my postdoctoral
training in the microbiome with the Kasper lab's unique interface of microbiology, chemistry, and immunology.
This study addresses two current unmet areas of basic research: the physiological purpose of DN T cells in the
gut, and the role of Fusobacteria in the composition of healthy microbiota. Improvements in these two areas
will help expand current understanding of the host immune-microbial interaction, and may also provide new
targets for therapeutic manipulation of the intestinal immune composition.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESLEY PASMAN其他文献
LESLEY PASMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 5.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 5.71万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 5.71万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 5.71万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 5.71万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 5.71万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 5.71万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 5.71万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 5.71万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 5.71万 - 项目类别:














{{item.name}}会员




